Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 4/20/2026 | $700.00 | Hold → Buy | Jefferies | |
| 4/16/2026 | $300.00 | Buy | BTIG Research | |
| 4/13/2026 | $218.00 | Neutral → Buy | Goldman | |
| 3/25/2026 | $185.00 → $165.00 | Market Perform | Telsey Advisory Group | |
| 3/9/2026 | $640.00 → $715.00 | Outperform | Telsey Advisory Group | |
| 3/6/2026 | $350.00 → $365.00 | Outperform | Telsey Advisory Group | |
| 2/20/2026 | $114.00 → $105.00 | Overweight | Analyst | |
| 2/20/2026 | $647.00 → $800.00 | Strong Buy | Raymond James |
144 - DICK'S SPORTING GOODS, INC. (0001089063) (Subject)
PRER14A - Ulta Beauty, Inc. (0001403568) (Filer)
DEF 14A - Sleep Number Corp (0000827187) (Filer)
Jefferies upgraded Ulta Beauty from Hold to Buy and set a new price target of $700.00
BTIG Research initiated coverage of Dick's Sporting Goods with a rating of Buy and set a new price target of $300.00
Goldman upgraded Williams-Sonoma from Neutral to Buy and set a new price target of $218.00
4 - GameStop Corp. (0001326380) (Issuer)
4 - GameStop Corp. (0001326380) (Issuer)
4 - GameStop Corp. (0001326380) (Issuer)
Newly Redesigned Guest Spaces Showcase GreenRow's Nature Inspired Designs GreenRow, a portfolio brand of Williams-Sonoma, Inc. (NYSE:WSM), the world's largest digital-first, design-led and sustainable home retailer, announced today the launch of a new hospitality partnership with The Inn at Serenbe, the award-winning wellness community located outside of Atlanta. Set on 2,000 acres, with 70% preserved green space, the Inn at Serenbe provides visitors access to a destination known for its connection to nature, including forest trails, a 25-acre organic farm, and critically acclaimed farm-to-table dining. This press release features multimedia. View the full release here: https://www.busin
Gear up for unbeatable deals with up to 80% off furniture, home decor and more, with new deals dropping every 24 hours.BOSTON, April 16, 2026 /PRNewswire/ -- Wayfair Inc. (NYSE:W), the destination for all things home, announced unbeatable deals for Way Day, taking place April 25–27. Starting on Monday, April 20, shoppers can take advantage of lead-in daily deals that will be dropping every 24 hours building up to three days of incredible savings across every home category. With the arrival of warmer weather, Way Day brings savings on everything you need to refresh your outdoor s
New Financing Program Extends the RH Experience With Financing Options Across Galleries, Outlets and RH.comSTAMFORD, Conn., April 14, 2026 /PRNewswire/ -- Synchrony (NYSE:SYF), a leading consumer financing company, today announced the launch of the RH Credit Card, a new financing solution designed for RH (NYSE:RH), a leading luxury home furnishings brand, to complement the RH experience and support clients as they furnish and complete thoughtfully-curated, design-driven spaces. The new RH Credit Card program offers cardholders a range of promotional financing options for purchases made at RH Galleries and Outlets across the U.S. and online at RH.com.
4 - RH (0001528849) (Issuer)
4 - RH (0001528849) (Issuer)
4 - RH (0001528849) (Issuer)
Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/13/2021. Application Category: ANDA, Application Number: 213111, Application Classification:
Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE ; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/13/2021. Application Category: ANDA, Application Number: 213111, Application Classification:
Submission status for RHODES PHARMS's drug DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE (ORIG-1) with active ingredient AMPHETAMINE ASPARTATE ; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE has changed to 'Approval' on 01/15/2021. Application Category: ANDA, Application Number: 213111, Application Classification:
Marlo Cormier to Step Down to Pursue Other Opportunities Reaffirms Second Quarter and Fiscal Year 2026 Guidance Sally Beauty Holdings, Inc. (NYSE:SBH) ("the Company") today announced that Adrianne Lee has been appointed Senior Vice President and Chief Financial Officer, effective April 28, 2026. Ms. Lee succeeds Marlo Cormier, who will be leaving the company, effective April 11, 2026, to pursue other opportunities. Ms. Lee brings significant relevant experience to the role, most recently serving as President and CFO at Bed Bath & Beyond. Ms. Lee joined Bed Bath & Beyond as CFO in 2020 and became Chief Administrative Officer in 2024 and President in 2025. Prior to that, she held senior
RH (NYSE:RH) announced today that Veronica Schnitzius is joining the Company as President, Chief Manufacturing & Sourcing Officer. Veronica will lead RH's efforts to build a global manufacturing platform that combines owned and operated, joint-ventured, and outsourced manufacturing for the Company's core furniture business, which represents 80% of RH brand revenues. The strategy will emulate the vertically integrated model of many of the world's largest and most profitable luxury brands that have a high level of control over the manufacturing, quality and capacity of their core business. Mrs. Schnitzius joins RH after a distinguished 24-year career at American Leather, a leading U.S. br
RH (NYSE:RH) today announced that David Stanchak has returned to the Company as Chief Real Estate and Transformation Officer. Mr. Stanchak has resumed his role leading the Company's Global Real Estate Expansion and North American Gallery Transformation, a position he held from May 2015 through May 2021. Mr. Stanchak will also be leading efforts to monetize the Company's significant portfolio of real estate assets in the United States and Europe. RH Chairman and Chief Executive Officer, Gary Friedman commented, "We are thrilled Dave is rejoining Team RH. His leadership expanding our Gallery platform globally, transforming our legacy stores into Design Galleries with integrated Restaurant
BOSTON, April 2, 2026 /PRNewswire/ -- Wayfair Inc. (NYSE:W), the destination for all things home, today announced it will release financial results for its first quarter ending March 31, 2026 before the opening of the market on April 30, 2026. Wayfair will host a conference call at 8 a.m. ET on Thursday, April 30 to review results. Investors and participants can register for the webcast in advance here.The call will also be available via dial-in here. The archived webcast will be available shortly after the call at https://investor.wayfair.com.About WayfairWayfair is the destina
RH (NYSE:RH) today announced that it will report financial results for the fourth quarter and fiscal year 2025 ended January 31, 2026, on Tuesday, March 31, 2026, after market close. RH's fourth quarter and fiscal year 2025 financial results will include a video presentation from Gary Friedman, RH Chairman and Chief Executive Officer, highlighting the Company's continued evolution and recent performance. The video presentation will be posted to the Company's investor relations website at ir.rh.com. RH leadership will host a live webcast of the video presentation followed by Q&A at 2:00 pm Pacific Time (5:00 pm Eastern Time) on March 31, 2026, at ir.rh.com. A replay will also be available
GameStop Corp. (NYSE:GME) ("GameStop" or the "Company") today released financial results for the fourth quarter and fiscal year ended January 31, 2026. The Company's consolidated financial statements, including GAAP and non-GAAP results, are below. The Company's Form 10-K and supplemental information can be found at https://investor.gamestop.com. FOURTH QUARTER OVERVIEW Net sales were $1.104 billion for the fourth quarter, compared to $1.283 billion in the prior year's fourth quarter. Selling, general and administrative ("SG&A") expenses were $241.5 million for the fourth quarter, compared to $282.5 million in the prior year's fourth quarter. Operating income was $135.2 million f
SC 13D/A - Sleep Number Corp (0000827187) (Subject)
SC 13D/A - Sleep Number Corp (0000827187) (Subject)
SC 13G/A - RH (0001528849) (Subject)